Latest neuralgia Stories
CyberKnife center offers nonsurgical option for lesser-known nerve disorder known as "suicide disease" LOUISVILLE, Ky., Oct.
CAMBRIDGE, England, October 6, 2014 /PRNewswire/ -- Agreement follows a very successful preceding collaboration with Dr Waxman with
MarketOptimizer.org adds “PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022” to its store.
CAMBRIDGE, September 23, 2014 /PRNewswire/ -- Highlights of the data: - CNV1014802 showed a statistically significant reduction in pain
MarketOptimizer.org adds “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014” to its store.
NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S.
ReportsnReports.com adds “Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 202” to its store. Dallas, TX (PRWEB) July 20, 2014 Neuropathic
CAMBRIDGE, England, June 16, 2014 /PRNewswire/ -- Convergence Pharmaceuticals ("Convergence" or "the
MELBOURNE, Australia and STAMFORD, Connecticut, June 3, 2014 /PRNewswire/ -- Spinifex Pharmaceuticals, a pain drug development company, today announces that it has appointed
MELBOURNE, Australia, May 27, 2014 /PRNewswire/ -- Expanded SAB will oversee development of EMA401, Company's lead program for
- a meat pie that is usually eaten at Christmas in Quebec